Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm

Hematopoietic cell transplantation from haploidentical donors (haploHCT) has facilitated treatment of AML and MDS by increasing donor availability and became more feasible since the introduction of post-transplant cyclophosphamide (ptCY). In our single-center retrospective analysis including 213 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieger, Max J., Stolz, Sebastian M., Müller, Antonia M., Schwotzer, Rahel, Nair, Gayathri, Schneidawind, Dominik, Manz, Markus G., Schanz, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555825/
https://www.ncbi.nlm.nih.gov/pubmed/37479752
http://dx.doi.org/10.1038/s41409-023-02042-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555825/
https://www.ncbi.nlm.nih.gov/pubmed/37479752
http://dx.doi.org/10.1038/s41409-023-02042-z

Ejemplares similares